Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Coral Gables, Florida
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Nevada
- Filings on record
- 603 filings
- On EDGAR
- CIK 1553643
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 52
News 8 of 149
Prospectuses and Registrations 8 of 47
- S-8 Registration statement for an employee plan Jun 18, 2026
- S-3ASR Automatic shelf registration May 13, 2026
- 424B3 Prospectus supplement for an offering Apr 9, 2026
- S-3 Shelf registration statement Apr 3, 2026
- 424B5 Prospectus supplement for an offering Jan 30, 2026
- 424B5 Prospectus supplement for an offering Nov 5, 2025
- FWP Free writing prospectus Nov 4, 2025
- S-8 Registration statement for an employee plan Jun 13, 2025
Proxies 8 of 33
- DEFA14A Extra proxy material Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2026
- PRE 14A Preliminary proxy statement Apr 6, 2026
- DEFA14A Extra proxy material Apr 11, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 11, 2025
- DEFA14A Extra proxy material Apr 9, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 9, 2024
- DEFA14A Extra proxy material Mar 31, 2023
Ownership 8 of 264
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 22, 2026
- SCHEDULE 13G Large holder reported a passive stake Jun 9, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 13, 2026
- SCHEDULE 13G Large holder reported a passive stake May 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Feb 17, 2026
Other 8 of 58
- EFFECT Notice that a registration became effective Apr 9, 2026
- CORRESP Reply to SEC staff Apr 7, 2026
- UPLOAD Comment letter from SEC staff Apr 7, 2026
- EFFECT Notice that a registration became effective Sep 12, 2024
- CORRESP Reply to SEC staff Sep 11, 2024
- UPLOAD Comment letter from SEC staff Sep 6, 2024
- EFFECT Notice that a registration became effective Aug 21, 2020
- CORRESP Reply to SEC staff Aug 19, 2020
Everything here comes from Relmada Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.